HAART is cost-effective and improves outcomes

Area of Science:

• Infectious Diseases
• Health Services Research
• Public Health

Background:

• Human Immunodeficiency Virus (HIV) care in managed care settings requires specific strategies.
• While Highly Active Antiretroviral Therapy (HAART) has transformed HIV into a manageable chronic illness for some, optimal outcomes are not universal.
• Existing data highlight the importance of experienced providers and coordinated care models.

Purpose of the Study:

• To outline a clear agenda for providers of HIV care within managed care settings.
• To emphasize the benefits of experienced providers, HAART adherence, and multidisciplinary care for HIV management.
• To advocate for well-timed, well-coordinated HIV care models, even if perceived as expensive.

Main Methods:

• Review of published data supporting the role of experienced HIV providers.
• Analysis of the impact of Highly Active Antiretroviral Therapy (HAART) on patient outcomes and costs.
• Discussion of the benefits of early treatment, patient adherence, and access to specialized care.

Main Results:

• Care from experienced HIV providers is associated with improved patient outcomes.
• HAART, adherence to treatment, and use of newer antiretroviral selection technologies lead to better viral load suppression and longer patient survival.
• Multidisciplinary programs offering wraparound services and coordinated care enhance patient management.

Conclusions:

• A model of well-timed, well-coordinated HIV care, delivered by experienced providers, is essential for optimal patient outcomes.
• This comprehensive care approach, though potentially costly, is more cost-effective than inpatient care or managing poorer outcomes in underserved or nonadherent populations.
• Improving quality of life for individuals with HIV is a paramount consideration in care delivery.